This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast Cancer.
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Neoplasms|Breast Neoplasms
Interventions: DRUG: Xentuzumab|DRUG: Abemaciclib|DRUG: Letrozole|DRUG: Anastrozole|DRUG: Fulvestrant|DRUG: Abemaciclib
Sponsor: Boehringer Ingelheim